Page 44 - Sohini Das

Serum Institute of India doubles Biocon investment to $300 million

The earlier investment by SILS in BBL was at a valuation of $4.9 billion, and the fresh $150-million investment pushes it up at $6 billion

Results preview: Ebitda margins of auto cos to take the wheel in Q4, again

Analysts indicate that in future, gross margins might come under pressure

GSK to bring Herpes Zoster vaccine Shingrix at one-third of US price: MD

Shingrix is for the prevention of shingles or what is also known as herpes zoster and also post-herpetic neuralgia in people aged 50 and above, says GSK Pharmaceuticals MD Bhushan Akshikar

Paediatricians bat for Covid-19 vaccine for children as cases rise

Doctors say they are seeing an increase in children with Covid infection

Temporary pause in US shipments from Sun Pharma's plant in Mohali

It implies that company has to take corrective action before releasing further batches to the US

Hospitals raise tech bet as India emerges as hub for complex surgeries

Experts say corporate hospitals are estimated to spend anything from 5 to 8 per cent of their top line on acquiring and upgrading technology

Brownfield expansion will give us 1,700 beds: Fortis Healthcare MD & CEO

Now that we have strength in our balance sheet, we can go for inorganic expansion, too, in markets where we are already present, says Dr Ashutosh Raghuvanshi, MD & CEO of Fortis Healthcare

Growing fertility treatment market set to see spike in M&A activity

M&A activity is set to increase in this space, feels industry, and more partnerships between organised players and mom-and-pop shops is in store

Jaguar Land Rover revs up for electric race; can it meet its 2030 target?

JLR aims to become electric-first luxury carmaker, to invest 15 bn pounds over next 5 years

Fortis Healthcare acquires Medeor Hospital for Rs 225 cr, plans expansion

Fortis Healthcare now has around 4000 operational beds across its network

Jaguar Land Rover raises EV drive bill to £15 bn to catch up with peers

Jefferies, in a report this month, noted that JLR had been focusing on improving profit and cash flow with an emphasis on selling higher-margin SUVs

Discounts are back to 2019 levels; is this a good time to buy a car?

Dealers across brands are slashing prices by Rs 20,000 to over Rs 1 lakh, depending car model

Audi sales double in Q1 of calendar year 2023, pre-owned car biz up 50%

Firm said this was the strongest quarter during past six years in India, with SUVs currently contributing over 60% of total sales

India business to boost pharma, after US sales prove to be a mixed bag

Hospitals to recover from sluggish Q3; diagnostics growth rate at pre-Covid levels

Former Jio-bp executive Kedar Apte to head M&M's global farm business

Apte comes from Jio-bp (a joint venture between Reliance & bp for mobility in India). He was working as the chief marketing officer at Jio-bp

Results preview: India business to put a spring in pharma's step

Hospitals to recover from sluggish Q3; diagnostics' growth rate at pre-Covid levels

Booster dose: Zydus likely to arm India with single-dose malaria drug

In Phase-2 trials now, pill also works against drug-resistant malaria strains

Awareness drive to immunity booster: India Inc gears up to meet Covid spike

While some firms have even suggested alternative therapies, many others are bringing back the mask mandate and calling for Covid-appropriate behaviour

Fertility chain Indira IVF seeks partnerships to expand clinics in India

Company says stakeholder Boston-based TA Associates is not seeking an exit for now

Tata Motors joins rivals, will hike PV prices from May 1 by 0.6%

Company earlier raised prices of its commercial vehicles by 5% as auto industry transitions to new emission norms